Surgical treatment for the vulvar vestibulitis syndrome.
OBJECTIVE
To study the outcome and complications of surgical treatment for vulvar vestibulitis syndrome and to identify patient characteristics that may have influenced the outcome.


METHODS
Relevant patient characteristics were extracted retrospectively from the medical records of 155 women aged 40 years or younger who had received surgical treatment for vulvar vestibulitis syndrome. To assess outcome and complications, 126 of these 155 women (81%) participated in a telephone interview, conducted 1 to 4 years after surgery.


RESULTS
After surgery 93% of the patients could have sexual intercourse compared with 78% before surgery; this increase was statistically significant (Mantel-Haenszel odds ratio 3.43, 95% confidence interval [CI] 1.48-7.96). In 62% of the women (95% CI 53-70%), sexual intercourse was painless after surgery. Eighty-nine percent (95% CI 84-95%) would recommend surgical treatment to other women experiencing vulvar vestibulitis syndrome. There were no major complications. Decreased lubrication during sexual arousal was the most frequently reported adverse effect (24%, 95% CI 16-32%), followed by the development of a Bartholin's cyst (6%, 95% CI 2-10%). More of the women aged 30 years or younger reported that they could have sexual intercourse after surgery, and more of them would recommend surgical treatment to other patients than women aged 31 years or older.


CONCLUSIONS
Surgical treatment for vulvar vestibulitis syndrome achieved high success rates with an acceptable rate of complications. Age of 30 years or younger was associated with a better outcome.


METHODS
III.
Traas
Maaike A F
MA
Department of Obstetrics and Gynecology, Rijnstate Hospital, Arnhem, the Netherlands. Mtraas@obgyn.umcn.nl
Bekkers
Ruud L M
RL
Dony
Julien M J
JM
Blom
Marlies
M
van Haren
Anneke W P
AW
Hendriks
Jan C M
JC
Vierhout
Mark E
ME
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D013577:Syndrome; D016896:Treatment Outcome; D014847:Vulvitis / Q000601:surgery*